ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
First-in-human phase 1 dose-escalation study of CAN04, a first-in-class interleukin-1 receptor accessory protein (IL1RAP) antibody in patients with solid tumours
British Journal of Cancer
◽
10.1038/s41416-021-01657-7
◽
2021
◽
Author(s):
Debbie Robbrecht
◽
Christiane Jungels
◽
Morten Mau Sorensen
◽
Iben Spanggaard
◽
Ferry Eskens
◽
...
Keyword(s):
Dose Escalation
◽
Phase 1
◽
Interleukin 1
◽
Solid Tumours
◽
Accessory Protein
◽
Dose Escalation Study
◽
Receptor Accessory Protein
Download Full-text
Related Documents
Cited By
References
1227 A phase 1, dose-escalation study of BIIB022 (anti-IGF-1R monoclonal antibody) in patients with relapsed or refractory solid tumours
European Journal of Cancer Supplements
◽
10.1016/s1359-6349(09)70439-2
◽
2009
◽
Vol 7
(2)
◽
pp. 128
◽
Cited By ~ 1
Author(s):
M. von Mehren
◽
C. Britten
◽
P. Piesolor
◽
K. Balogh
◽
A. Bartok
◽
...
Keyword(s):
Monoclonal Antibody
◽
Dose Escalation
◽
Phase 1
◽
Solid Tumours
◽
Dose Escalation Study
Download Full-text
Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study
The Lancet Oncology
◽
10.1016/s1470-2045(12)70476-x
◽
2012
◽
Vol 13
(12)
◽
pp. 1234-1241
◽
Cited By ~ 138
Author(s):
Christoph Mamot
◽
Reto Ritschard
◽
Andreas Wicki
◽
Gregor Stehle
◽
Thomas Dieterle
◽
...
Keyword(s):
Dose Escalation
◽
Phase 1
◽
Solid Tumours
◽
Dose Escalation Study
Download Full-text
Bosutinib plus capecitabine for selected advanced solid tumours: results of a phase 1 dose-escalation study
British Journal of Cancer
◽
10.1038/bjc.2014.508
◽
2014
◽
Vol 111
(11)
◽
pp. 2058-2066
◽
Cited By ~ 12
Author(s):
S J Isakoff
◽
D Wang
◽
M Campone
◽
A Calles
◽
E Leip
◽
...
Keyword(s):
Dose Escalation
◽
Phase 1
◽
Solid Tumours
◽
Dose Escalation Study
Download Full-text
Phase 1 dose-escalation study of S-222611, an oral reversible dual tyrosine kinase inhibitor of EGFR and HER2, in patients with solid tumours
European Journal of Cancer
◽
10.1016/j.ejca.2014.11.003
◽
2015
◽
Vol 51
(2)
◽
pp. 137-145
◽
Cited By ~ 4
Author(s):
J. Spicer
◽
R. Baird
◽
A. Suder
◽
N. Cresti
◽
J. Garcia Corbacho
◽
...
Keyword(s):
Tyrosine Kinase
◽
Tyrosine Kinase Inhibitor
◽
Dose Escalation
◽
Kinase Inhibitor
◽
Phase 1
◽
Solid Tumours
◽
Dose Escalation Study
Download Full-text
152O A phase 1, first-in-human dose escalation study of ETC-159 in advanced or metastatic solid tumours
Annals of Oncology
◽
10.1093/annonc/mdw579.004
◽
2016
◽
Vol 27
(suppl_9)
◽
Cited By ~ 7
Author(s):
V. Teneggi
◽
M. Ng
◽
D.S. Tan
◽
V. Subbiah
◽
C. Weekes
◽
...
Keyword(s):
Dose Escalation
◽
Phase 1
◽
Solid Tumours
◽
Dose Escalation Study
◽
Human Dose
Download Full-text
152O A phase 1, first-in-human dose escalation study of ETC-159 in advanced or metastatic solid tumours
Annals of Oncology
◽
10.1016/s0923-7534(21)00310-0
◽
2016
◽
Vol 27
◽
pp. ix47
Author(s):
V. Teneggi
◽
M. Ng
◽
D.S. Tan
◽
V. Subbiah
◽
C. Weekes
◽
...
Keyword(s):
Dose Escalation
◽
Phase 1
◽
Solid Tumours
◽
Dose Escalation Study
◽
Human Dose
Download Full-text
A phase 1 dose-escalation study of veliparib with bimonthly FOLFIRI in patients with advanced solid tumours
British Journal of Cancer
◽
10.1038/s41416-018-0003-3
◽
2018
◽
Vol 118
(7)
◽
pp. 938-946
◽
Cited By ~ 6
Author(s):
Jordan Berlin
◽
Ramesh K. Ramanathan
◽
John H. Strickler
◽
Deepa S. Subramaniam
◽
John Marshall
◽
...
Keyword(s):
Dose Escalation
◽
Phase 1
◽
Solid Tumours
◽
Dose Escalation Study
Download Full-text
1209 POSTER ONX 0912, a Novel Oral Proteasome Inhibitor (PI), in Patients (pts) With Advanced Refractory or Recurrent Solid Tumours: a Phase 1, Open-label, Dose Escalation Study
European Journal of Cancer
◽
10.1016/s0959-8049(11)70821-8
◽
2011
◽
Vol 47
◽
pp. S147
Author(s):
K. Papadopoulos
◽
D. Mendelson
◽
A.W. Tolcher
◽
H.A. Burris
◽
M. Gordon
◽
...
Keyword(s):
Dose Escalation
◽
Proteasome Inhibitor
◽
Phase 1
◽
Solid Tumours
◽
Open Label
◽
Dose Escalation Study
◽
Label Dose
Download Full-text
Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609A in China
Case Medical Research
◽
10.31525/ct1-nct03998345
◽
2019
◽
Author(s):
Keyword(s):
Dose Escalation
◽
Phase 1
◽
Open Label
◽
Dose Escalation Study
◽
Label Dose
Download Full-text
Faculty Opinions recommendation of Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.717955175.793461372
◽
2012
◽
Author(s):
Philip Rosenthal
Keyword(s):
Liver Metastases
◽
Dose Escalation
◽
Phase 1
◽
Dose Escalation Study
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close